| SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE |
SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE
Table
18.1: Details of Basic and Dilutive Loss Per Share
| | |
2026 | | |
2025 | |
| | |
For the Three Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| Basic net loss per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Net loss including non-controlling interests | |
$ | (2,561,786 | ) | |
$ | (10,248,486 | ) |
| Less: Net loss attributable to non-controlling interest | |
| (433,324 | ) | |
| - | |
| Net loss attributable to common stockholders - basic | |
$ | (2,128,462 | ) | |
$ | (10,248,486 | ) |
| Denominator | |
| | | |
| | |
| Weighted average shares outstanding - basic | |
| 4,561,976 | | |
| 658,218 | |
| Basic net loss per share attributable to common stockholders | |
$ | (0.47 | ) | |
$ | (15.57 | ) |
| Diluted net loss per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Net loss attributable to common stockholders - basic | |
$ | (2,128,462 | ) | |
$ | (10,248,486 | ) |
| Add back interest for subordinated convertible promissory note | |
| - | | |
| 5,000 | |
| Net loss attributable to common stockholders - diluted | |
$ | (2,128,462 | ) | |
$ | (10,243,486 | ) |
| Denominator | |
| | | |
| | |
| Weighted average shares outstanding - basic | |
| 4,561,976 | | |
| 658,218 | |
| Weighted-average effect of potentially dilutive securities: | |
| | | |
| | |
| Conversion of subordinated convertible promissory note | |
| - | | |
| 3,360 | |
| Conversion of Series A Convertible Preferred Stock | |
| - | | |
| 77,860 | |
| Conversion of Series B Convertible Preferred Stock | |
| - | | |
| 38 | |
| Conversion of Series C Convertible Preferred Stock | |
| - | | |
| 1,212 | |
| Conversion of Preferred Stock | |
| - | | |
| 1,212 | |
| Exercise of investor and placement agent warrants | |
| - | | |
| 640,243 | |
| Weighted average shares outstanding - diluted | |
| 4,561,976 | | |
| 1,383,507 | |
| Dilutive net loss per share attributable to common stockholders | |
$ | (0.47 | ) | |
$ | (7.40 | ) |
|
SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE
| | |
2025 | | |
2024 | |
| Table 21.1: Details of Basic and Dilutive (Loss)/Earnings Per Share |
| | |
For the Year Ended December 31, | |
| | |
2025 | | |
2024 | |
| Basic net (loss)/income per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Net (loss)/income including non-controlling interests | |
$ | (24,059,084 | ) | |
$ | 1,229,601 | |
| Less: Net loss attributable to non-controlling interest | |
| (393,376 | ) | |
| - | |
| Net (loss)/income attributable to Common Stockholders - basic | |
| (23,665,708 | ) | |
| 1,229,601 | |
| Denominator | |
| | | |
| | |
| Weighted average shares outstanding - basic | |
| 1,760,310 | | |
| 282,437 | |
| Basic net (loss)/income per share attributable to Common Stockholders | |
$ | (13.44 | ) | |
$ | 4.35 | |
| Diluted net (loss)/income per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Net (loss)/income attributable to Common Stockholders - basic | |
$ | (23,665,708 | ) | |
$ | 1,229,601 | |
| Add back interest for subordinated convertible promissory note | |
| 43,333 | | |
| 276,667 | |
| Net (loss)/income attributable to Common Stockholders - diluted | |
$ | (23,622,375 | ) | |
$ | 1,506,268 | |
| Denominator | |
| | | |
| | |
| Weighted average shares outstanding - basic | |
| 1,760,310 | | |
| 282,437 | |
| Weighted-average effect of potentially dilutive securities: | |
| | | |
| | |
| Conversion of subordinated convertible promissory note | |
| 3,333 | | |
| 58,347 | |
| Conversion of Series A Convertible Preferred Stock | |
| - | | |
| 70,203 | |
| Conversion of Series B Convertible Preferred Stock | |
| - | | |
| 175,182 | |
| Conversion of Series C Convertible Preferred Stock | |
| - | | |
| 1,212 | |
| Conversion of Preferred Stock | |
| - | | |
| 1,212 | |
| Exercise of investor and placement agent warrants | |
| - | | |
| 317,548 | |
| Weighted average shares outstanding - diluted | |
| 1,763,643 | | |
| 904,929 | |
| Dilutive net (loss)/income per share attributable to Common Stockholders | |
$ | (13.39 | ) | |
$ | 1.66 | |
|
| SCHEDULE OF DILUTIVE EFFECT OF SECURITIES EXCLUDED FROM DILUTIVE EPS DUE TO ANTI-DILUTIVE EFFECT |
SCHEDULE OF DILUTIVE EFFECT OF SECURITIES EXCLUDED FROM DILUTIVE EPS DUE TO ANTI-DILUTIVE EFFECT
Table
18.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect
| | |
2026 | | |
2025 | |
| | |
For the Three Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| Conversion of Series B Convertible Preferred Stock | |
| 1,347 | | |
| - | |
| Conversion of Series C Convertible Preferred Stock | |
| 1,202 | | |
| - | |
| Conversion of Series D Convertible Preferred Stock | |
| 10,092 | | |
| - | |
| Conversion of Series E Convertible Preferred Stock | |
| 51 | | |
| - | |
| Conversion convertible preferred stock | |
| 51 | | |
| - | |
|
SCHEDULE OF DILUTIVE EFFECT OF SECURITIES EXCLUDED FROM DILUTIVE EPS DUE TO ANTI-DILUTIVE EFFECT
| | |
2025 | | |
2024 | |
| Table 21.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect |
| | |
For the Year Ended December 31, | |
| | |
2025 | | |
2024 | |
| Conversion of Series A Convertible Preferred Stock | |
| 92,332 | | |
| - | |
| Conversion of Series B Convertible Preferred Stock | |
| 28,090 | | |
| - | |
| Conversion of Series C Convertible Preferred Stock | |
| 1,202 | | |
| - | |
| Conversion of Series D Convertible Preferred Stock | |
| 10,092 | | |
| - | |
| Conversion of Series E Convertible Preferred Stock | |
| 2 | | |
| - | |
| Exercise of investor and placement agent warrants | |
| 922,845 | | |
| 317,548 | |
| Antidilutive securities | |
| 922,845 | | |
| 317,548 | |
|